MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, APTOF had $339K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$339K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss for the period
-5,123 -12,586
Stock-based compensation
44 391
Accounts payable, related party
-0
Depreciation of property and equipment
11 7
Loss on disposal of property and equipment
0 0
Amortization of right-of-use assets
100 194
Interest on lease liabilities
8 21
Interest on loan payable to related parties
220 276
Prepaid expenses
156 -396
Other assets
366 1,470
Operating lease payments
116 229
Related party payable
0 -
Accounts payable
198 1,621
Accrued liabilities
-610 2,641
Cash used in operating activities
-7,411 -8,738
Proceeds from loans payable with related parties
7,750 2,600
Repayment of loan with related party
0 100
Issuance of common shares and warrants-Registered Direct Offering
0 0
Issuance of common shares and warrants-January Two Thousand And Twenty Four Public Offering
0 0
Issuance of common shares and warrants-Hanmi Private Placement
0 0
Proceeds from issuance of common stock-Committed Equity Facility
0 0
Proceeds from issuance of common stock-The2022Atm Offering
0 0
Proceeds from issuance of common stock-The2025ATMOffering
0 828
Proceeds from issuance of common stock-Employee Stock Purchase Plan
0 1
Cash provided by financing activities
7,750 3,329
Disposal of property and equipment
0 0
Cash provided by investing activities
0 0
Decrease in cash, cash equivalents and restricted cash and restricted cash equivalents
339 -5,409
Cash and cash equivalents at beginning of period
6,707 -
Cash and cash equivalents at end of period
1,637 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Aptose Biosciences Inc. (APTOF)

Aptose Biosciences Inc. (APTOF)